Camarillo Company Moves Closer to Merger
Camarillo-based BioSource Industries Inc. says the final regulatory hurdle has been removed to its proposed merger with Burlingame-based Tago Inc.
James H. Chamberlain, BioSource’s president and chief executive, said the Securities and Exchange Commission approved the registration of securities to be issued to shareholders of the merged company, which will be called BioSource International Inc.
The merger will become effective next Monday if, as expected, it receives approval that morning from Tago’s shareholders, Chamberlain said.
BioSource International, to be headquartered in Camarillo, will have 40 employees and estimated annual revenues of $6 million, said BioSource Treasurer Anna Anderson.
BioSource develops and markets products used in medical research and diagnosis. The company plans to base its manufacturing unit in Burlingame.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
